Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,764 | 33,550 | 47,930 | 66,968 | 16,811 |
| Marketable Securities | 32,572 | 41,980 | 43,968 | 39,724 | 33,814 |
| Receivables | 1,207 | 53 | 66 | 36 | 271 |
| Other current assets | 1,961 | 3,538 | 2,678 | 3,013 | 2,462 |
| TOTAL | $85,765 | $90,779 | $105,870 | $121,276 | $65,995 |
| Non-Current Assets | |||||
| PPE Net | 15,165 | 14,481 | 10,202 | 5,571 | 6,048 |
| Intangibles | 4,671 | 4,671 | 4,671 | 4,671 | 4,671 |
| Other Non-Current Assets | 2,445 | 2,628 | 2,975 | 2,598 | 2,550 |
| TOTAL | $22,281 | $21,780 | $17,848 | $12,840 | $13,269 |
| Total Assets | $108,046 | $112,559 | $123,718 | $134,116 | $79,264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,290 | 4,290 | 4,290 | 4,203 | 3,443 |
| Accounts payable and accrued liabilities | 4,919 | 2,348 | 2,236 | 2,068 | 3,107 |
| Accrued Expenses | 9,846 | 8,263 | 5,293 | 4,858 | 4,609 |
| Other current liabilities | 2,942 | 2,531 | 204 | 257 | 350 |
| TOTAL | $36,183 | $39,299 | $30,396 | $23,240 | $20,734 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,784 | 8,856 | 9,929 | 11,001 | 10,949 |
| Deferred Revenues | 10,186 | 21,857 | 18,319 | 11,745 | 8,259 |
| Other Non-Current Liabilities | 359 | 342 | 336 | 0 | 0 |
| TOTAL | $15,099 | $9,213 | $10,281 | $11,019 | $12,941 |
| Total Liabilities | $51,282 | $48,512 | $40,677 | $34,259 | $33,675 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,657 | 42,289 | 42,127 | 42,018 | 42,004 |
| Common Shares | 44 | 42 | 42 | 42 | 32 |
| Retained earnings | -327,659 | -306,176 | -287,717 | -270,710 | -256,048 |
| Other shareholders' equity | -250 | 1 | -111 | -177 | -206 |
| TOTAL | $56,764 | $64,047 | $83,041 | $99,857 | $45,589 |
| Total Liabilities And Equity | $108,046 | $112,559 | $123,718 | $134,116 | $79,264 |